Page last updated: 2024-10-19

niacinamide and Conus Medullaris Syndrome

niacinamide has been researched along with Conus Medullaris Syndrome in 3 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Research Excerpts

ExcerptRelevanceReference
"Numbers of surviving neurons and glial scar sizes were determined using Nissl and hematoxylin-eosin staining, respectively."1.51TGN-020 alleviates edema and inhibits astrocyte activation and glial scar formation after spinal cord compression injury in rats. ( Bi, J; Cao, Y; Fan, Z; Guo, W; Jia, Z; Li, G; Li, J; Xu, W; Zhang, M, 2019)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, J1
Jia, Z1
Xu, W1
Guo, W1
Zhang, M1
Bi, J1
Cao, Y1
Fan, Z1
Li, G1
Smidt-Hansen, T1
Folkmar, TB1
Fode, K1
Agerbaek, M1
Donskov, F1
Bul'on, VV1
Kuznetsova, NN1
Selina, EN1
Kovalenko, AL1
Alekseeva, LE1
Sapronov, NS1

Other Studies

3 other studies available for niacinamide and Conus Medullaris Syndrome

ArticleYear
TGN-020 alleviates edema and inhibits astrocyte activation and glial scar formation after spinal cord compression injury in rats.
    Life sciences, 2019, Apr-01, Volume: 222

    Topics: Animals; Astrocytes; Cicatrix; Edema; Female; Neuroglia; Niacinamide; Rats; Rats, Sprague-Dawley; Sp

2019
Combination of zoledronic Acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2013, Volume: 71, Issue:9

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Beva

2013
Neuroprotective effect of cytoflavin during compression injury of the spinal cord.
    Bulletin of experimental biology and medicine, 2005, Volume: 139, Issue:4

    Topics: Animals; Drug Combinations; Flavin Mononucleotide; Inosine Diphosphate; Male; Neuroprotective Agents

2005